Donald L. Hagan LLC’s Gilead Sciences GILD Stock Holding History

Donald L. Hagan LLC’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-19,504	Closed	-$1.67M	–	107
2022 Q4	$1.67M	Sell	19,504 -266	-1%	-$21.1K	1.05%	17
2022 Q3	$1.22M	Buy	19,770 +21	+0.1%	+$1.32K	0.87%	18
2022 Q2	$1.22M	Buy	19,749 +1,247	+7%	+$77.2K	0.78%	27
2022 Q1	$1.1M	Buy	18,502 +1,029	+6%	+$65.8K	0.62%	38
2021 Q4	$1.27M	Buy	17,473 +780	+5%	+$53.7K	0.66%	29
2021 Q3	$1.17M	Buy	16,693 +170	+1%	+$11.9K	0.68%	30
2021 Q2	$1.14M	Buy	16,523 +7,881	+91%	+$526K	0.67%	29
2021 Q1	$559K	Buy	+8,642	New	+$557K	0.37%	66
2016 Q2	–	Sell	-920	Closed	-$85K	–	167
2016 Q1	$85K	Buy	+920	New	+$83K	0.08%	108
2015 Q4	–	Sell	-650	Closed	-$64K	–	156
2015 Q3	$64K	Buy	+650	New	+$72.2K	0.06%	122

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Donald L. Hagan LLC's GILD Position: Q1 2023 in Review

Donald L. Hagan LLC sold out of Gilead Sciences (GILD) in Q1 2023, closing a stake of 19,504 shares — an estimated $1.67M sold.

Donald L. Hagan LLC first reported a position in GILD in Q3 2015 and held it in 10 quarters. The position peaked at $1.67M in Q4 2022. 1,735 funds tracked by Wall St. Rank hold GILD as of Q1 2023.

Donald L. Hagan LLC reported no remaining Gilead Sciences position as of Q1 2023 after selling out during the quarter.
Donald L. Hagan LLC sold 19,504 Gilead Sciences shares in Q1 2023, an estimated $1.67M.
Donald L. Hagan LLC first reported a position in Gilead Sciences in Q3 2015 and held it in 10 quarters.
Donald L. Hagan LLC's Gilead Sciences position peaked at $1.67M in Q4 2022.
1,735 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2023.

Based on Donald L. Hagan LLC's 13F filing for Q1 2023, filed 18 Apr 2023.